Drawing based on the label description. No photo yet.
A LGX 50mg pill
Pill with imprint A LGX 50mg is orange & pink, capsule, 22 mm and has been identified as Encorafenib 50 mg. It is used for melanoma. It is supplied by Array Biopharma Inc.
Encorafenib 50 mg
- Imprint
- A LGX 50mg
- Strength
- 50 mg
- Used for
- Melanoma
- Color
- Orange, Pink
- Shape
- Capsule / oblong
- Size
- 22 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Array Biopharma Inc
- NDC
- 70255-050, 70255-050-28
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Encorafenib used for?
Encorafenib is used for melanoma.
Official uses from the US prescribing label
BRAF V600E or V600K Mutation–Positive Unresectable or Metastatic Melanoma
BRAFTOVI is indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-authorized test.
BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (mCRC)
- BRAFTOVI is indicated, in combination with cetuximab and fluorouracil-based chemotherapy, for the treatment of adult patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, as detected by an FDA-authorized test.
- BRAFTOVI is indicated, in combination with cetuximab, for the treatment of adult patients with mCRC with a BRAF V600E mutation, as detected by an FDA-authorized test, after prior therapy.
BRAF V600E Mutation-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)
BRAFTOVI is indicated, in combination with binimetinib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-authorized test.
Limitations of Use
BRAFTOVI is not indicated for treatment of patients with wild-type BRAF melanoma, wild-type BRAF CRC, or wild-type BRAF NSCLC.
From the FDA-approved label on DailyMed (published Mar 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows A LGX 50mg. The parts can be split between the two sides, so turn the pill over and check both.
- It is orange & pink, capsule, 22 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Braftovi.
Ingredients
Active: Encorafenib
Inactive: Copovidone K25-31, Poloxamer 188, Microcrystalline Cellulose, Succinic Acid, Crospovidone, Unspecified, Silicon Dioxide, Magnesium Stearate, Gelatin, Unspecified, Titanium Dioxide, Ferric Oxide Red, Ferric Oxide Yellow, Ferrosoferric Oxide, Shellac, Propylene Glycol
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
IPX203 350
Carbidopa and Levodopa 87.5 mg / 350 mg
Orange & white, capsule, 23 mm
Used for Parkinson's disease
-
SD TC 5 mg
Tacrolimus 5 mg
Orange, capsule, 21 mm
Used for eczema
-
R 8
Fenoprofen Calcium 300 mg
Orange & yellow, capsule, 23 mm
Used for pain and rheumatoid arthritis
-
C248
Darunavir 600 mg
Orange, capsule, 21 mm
Used for HIV
-
E 89
Venlafaxine Hydrochloride 150 mg
Orange, capsule, 21 mm
Used for depression and anxiety
-
214
Gabapentin 400 mg
Orange, capsule, 21 mm
Used for bipolar disorder and focal seizures